Rybelsus 3 mg (Semaglutide) 10 Tablets
Rybelsus 3 mg (Semaglutide) is the world's first oral GLP-1 receptor agonist, offering the benefits of Ozempic in a pill.
Manufacturer: Novo Nordisk (India). This 3 mg pack represents Step 1 (Initiation). It contains 10 tablets per blister. This dose is strictly for dose escalation and acclimatization. It is not intended for effective glycemic control or significant weight loss yet.
Mechanism of Action ("Adaptation Phase"):
Rybelsus mimics the natural hormone GLP-1. The 3 mg dose gently introduces the drug to your system to mitigate gastrointestinal side effects before stepping up to the therapeutic doses of 7 mg and 14 mg.
✅ Goal: To prepare your body for higher doses without severe nausea.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 17.04.2026
What Customers Say
No reviews yet
Your review can be the first!